Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Amarin (AMRN – Research Report), Arrowhead Pharmaceuticals (ARWR – Research Report) and RegenXBio (RGNX – Research Report).
In a report released today, Paul Choi from Goldman Sachs maintained a Sell rating on Amarin, with a price target of $1.50. The company’s shares closed last Monday at $1.41, close to its 52-week low of $1.11.
According to TipRanks.com, Choi is a 4-star analyst with an average return of
Currently, the analyst consensus on Amarin is a Moderate Buy with an average price target of $6.75.
Arrowhead Pharmaceuticals (ARWR)
Goldman Sachs analyst Madhu Kumar maintained a Buy rating on Arrowhead Pharmaceuticals today and set a price target of $66.00. The company’s shares closed last Monday at $36.05, close to its 52-week low of $27.87.
According to TipRanks.com, Kumar is a 5-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Arrowhead Pharmaceuticals with a $73.14 average price target, representing a 100.7% upside. In a report issued on May 11, Robert W. Baird also upgraded the stock to Buy with a $60.00 price target.
Morgan Stanley analyst Vikram Purohit maintained a Buy rating on RegenXBio today and set a price target of $47.00. The company’s shares closed last Monday at $19.56, close to its 52-week low of $18.69.
According to TipRanks.com, Purohit has 0 stars on 0-5 stars ranking scale with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for RegenXBio with a $47.67 average price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on AMRN:
- HireRight Holdings Corp (HRT) Initiated with a Buy at Jefferies
- Analysts Offer Insights on Industrial Goods Companies: Nordson (NDSN) and Parker Hannifin (PH)
- Analysts Are Bullish on These Healthcare Stocks: Alnylam Pharma (ALNY), Cytokinetics (CYTK)
- Wall Street Analysts Are Bullish on Top Consumer Goods Picks
- Monkeypox Outbreak is Pushing Up Smallpox Vaccine Makers’ Stocks